For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240531:nRSe5492Qa&default-theme=true
RNS Number : 5492Q Animalcare Group PLC 31 May 2024
Animalcare Group Plc
(the "Company" or the "Group")
Total Voting Rights - 31 May 2024
31 May 2024. For the purposes of the Financial Conduct Authority's Disclosure
Guidance and Transparency Rules ("DTRs"), the Company's issued share capital
as at 31 May 2024 consisted of 60,374,268 ordinary shares of 20 pence each in
the Company ("Ordinary Shares"). No shares are held in Treasury. Therefore,
the total number of voting rights in the Company was 60,374,268.
The above figure of 60,374,268 may be used by shareholders in the Company as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the DTRs.
For further information, please contact:
Animalcare Group Plc +44 (0)1904 487 687
Chris Brewster, Chief Financial Officer and communications@animalcaregroup.com
Company Secretary
Stifel Nicolaus Europe Limited Tel: +44 (0)20 7710 7600
(Nominated Advisor & Joint Broker)
Ben Maddison
Nicholas Harland
Francis North
Panmure Gordon +44 (0)20 7886 2500
(Joint Broker)
Corporate Finance
Freddy Crossley/Emma Earl
Corporate Banking
Rupert Dearden
About Animalcare
Animalcare Group plc is a UK AIM-listed
international development-focused veterinary sales and marketing
organisation. Animalcare operates in seven countries and exports to
approximately 40 countries in Europe and worldwide. The Group is focused on
bringing new and innovative products to market through its own development
pipeline, partnerships and via acquisition.
For more information, please visit www.animalcaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRSDIFASELSESI